CN1693416B - A kind of fluorescent microsphere and its spray-drying preparation method and application - Google Patents
A kind of fluorescent microsphere and its spray-drying preparation method and application Download PDFInfo
- Publication number
- CN1693416B CN1693416B CN 200510025591 CN200510025591A CN1693416B CN 1693416 B CN1693416 B CN 1693416B CN 200510025591 CN200510025591 CN 200510025591 CN 200510025591 A CN200510025591 A CN 200510025591A CN 1693416 B CN1693416 B CN 1693416B
- Authority
- CN
- China
- Prior art keywords
- microspheres
- fluorescent
- spray
- particle
- microsphere
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000004005 microsphere Substances 0.000 title claims abstract description 48
- 238000001694 spray drying Methods 0.000 title claims abstract description 17
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 239000002245 particle Substances 0.000 claims abstract description 29
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000010931 gold Substances 0.000 claims abstract description 27
- 229910052737 gold Inorganic materials 0.000 claims abstract description 27
- 229920000642 polymer Polymers 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 21
- 239000002105 nanoparticle Substances 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 11
- 239000002246 antineoplastic agent Substances 0.000 claims abstract 4
- 229940041181 antineoplastic drug Drugs 0.000 claims abstract 4
- 239000006249 magnetic particle Substances 0.000 claims description 30
- 239000000243 solution Substances 0.000 claims description 25
- 239000000975 dye Substances 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 19
- 238000001035 drying Methods 0.000 claims description 13
- 229920002521 macromolecule Polymers 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000011259 mixed solution Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 239000011246 composite particle Substances 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 239000012159 carrier gas Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 3
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims description 3
- 102000039446 nucleic acids Human genes 0.000 claims description 2
- 108020004707 nucleic acids Proteins 0.000 claims description 2
- 150000007523 nucleic acids Chemical class 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- BCHZICNRHXRCHY-UHFFFAOYSA-N 2h-oxazine Chemical compound N1OC=CC=C1 BCHZICNRHXRCHY-UHFFFAOYSA-N 0.000 claims 1
- AGIJRRREJXSQJR-UHFFFAOYSA-N 2h-thiazine Chemical compound N1SC=CC=C1 AGIJRRREJXSQJR-UHFFFAOYSA-N 0.000 claims 1
- 239000004971 Cross linker Substances 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- 239000011162 core material Substances 0.000 claims 1
- BVBRZOLXXOIMQG-UHFFFAOYSA-N fluoroborane Chemical compound FB BVBRZOLXXOIMQG-UHFFFAOYSA-N 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 239000011261 inert gas Substances 0.000 claims 1
- 230000001788 irregular Effects 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 239000001022 rhodamine dye Substances 0.000 claims 1
- 238000001179 sorption measurement Methods 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 abstract description 37
- 230000000694 effects Effects 0.000 abstract description 5
- 239000002122 magnetic nanoparticle Substances 0.000 abstract description 5
- 210000004881 tumor cell Anatomy 0.000 abstract description 4
- 230000005284 excitation Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000002372 labelling Methods 0.000 abstract 1
- 230000007096 poisonous effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 description 18
- 235000013339 cereals Nutrition 0.000 description 16
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 15
- 229940098773 bovine serum albumin Drugs 0.000 description 15
- 229910004613 CdTe Inorganic materials 0.000 description 14
- 238000002156 mixing Methods 0.000 description 12
- 238000000015 thermotherapy Methods 0.000 description 11
- 238000005507 spraying Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 239000002243 precursor Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 229940079593 drug Drugs 0.000 description 6
- 238000011275 oncology therapy Methods 0.000 description 6
- 239000004065 semiconductor Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 239000001856 Ethyl cellulose Substances 0.000 description 4
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 235000019325 ethyl cellulose Nutrition 0.000 description 4
- 229920001249 ethyl cellulose Polymers 0.000 description 4
- 239000007850 fluorescent dye Substances 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002096 quantum dot Substances 0.000 description 4
- -1 rare-earth compound Chemical class 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000011258 core-shell material Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000002626 targeted therapy Methods 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910000673 Indium arsenide Inorganic materials 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 150000002433 hydrophilic molecules Chemical class 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 239000011147 inorganic material Substances 0.000 description 2
- 239000006193 liquid solution Substances 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 150000004893 oxazines Chemical class 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical class [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000003451 thiazide diuretic agent Substances 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 238000002525 ultrasonication Methods 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- FBTUMDXHSRTGRV-ALTNURHMSA-N zorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(\C)=N\NC(=O)C=1C=CC=CC=1)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 FBTUMDXHSRTGRV-ALTNURHMSA-N 0.000 description 2
- 229960000641 zorubicin Drugs 0.000 description 2
- INGSNVSERUZOAK-VXGBXAGGSA-N (2r)-2-phenyl-2-[(2r)-piperidin-1-ium-2-yl]acetate Chemical compound C([C@@H]1[C@H](C(=O)O)C=2C=CC=CC=2)CCCN1 INGSNVSERUZOAK-VXGBXAGGSA-N 0.000 description 1
- LCSKNASZPVZHEG-UHFFFAOYSA-N 3,6-dimethyl-1,4-dioxane-2,5-dione;1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1.CC1OC(=O)C(C)OC1=O LCSKNASZPVZHEG-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229910004262 HgTe Inorganic materials 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229920002494 Zein Polymers 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000004611 cancer cell death Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002498 deadly effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- JBFHTYHTHYHCDJ-UHFFFAOYSA-N gamma-caprolactone Chemical compound CCC1CCC(=O)O1 JBFHTYHTHYHCDJ-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 239000005543 nano-size silicon particle Substances 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 239000002078 nanoshell Substances 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229920001483 poly(ethyl methacrylate) polymer Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 239000010695 polyglycol Substances 0.000 description 1
- 229920000151 polyglycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000006862 quantum yield reaction Methods 0.000 description 1
- 229910052761 rare earth metal Inorganic materials 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- JACPFCQFVIAGDN-UHFFFAOYSA-M sipc iv Chemical class [OH-].[Si+4].CN(C)CCC[Si](C)(C)[O-].C=1C=CC=C(C(N=C2[N-]C(C3=CC=CC=C32)=N2)=N3)C=1C3=CC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 JACPFCQFVIAGDN-UHFFFAOYSA-M 0.000 description 1
- 230000005476 size effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000005019 zein Substances 0.000 description 1
- 229940093612 zein Drugs 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种荧光微球及其喷雾干燥制备方法和应用，本发明通过喷雾干燥方法将近红外荧光物质和磁性纳米颗粒包埋到高分子微球中，或者是将金纳米颗粒与磁性纳米颗粒包埋到高分子微球中，成球与包埋一步完成。微球中还可以进一步包埋抗癌药物，微球表面还将连接具有识别功能的生物分子。本发明所获得的微球可通过近红外荧光物质或金纳米颗粒在激发光的激发下所产生的热效应来摧毁肿瘤细胞，或同时利用抗癌药物的毒杀作用和近红外荧光物质或金纳米颗粒产生的热效应来治疗肿瘤。微球中的磁性纳米颗粒可将微球定位或固定于肿瘤部位。本发明获得的微球还可用于生物医学的标记示踪中。The invention discloses a fluorescent microsphere and its spray-drying preparation method and application. The invention uses a spray-drying method to embed near-infrared fluorescent substances and magnetic nanoparticles into polymer microspheres, or to embed gold nanoparticles and magnetic nanoparticles Particles are embedded in polymer microspheres, and sphere formation and embedding are completed in one step. Anticancer drugs can be further embedded in the microspheres, and the surface of the microspheres will also be connected with biomolecules with recognition functions. The microspheres obtained by the present invention can destroy tumor cells through the thermal effect produced by near-infrared fluorescent substances or gold nanoparticles excited by excitation light, or use the poisonous effect of anticancer drugs and near-infrared fluorescent substances or gold nanoparticle The thermal effect generated by the particles is used to treat tumors. Magnetic nanoparticles in the microspheres can localize or immobilize the microspheres at the tumor site. The microspheres obtained by the present invention can also be used in biomedical labeling and tracing.
Description
Technical field
What the present invention relates to is a kind of fluorescent microsphere and preparation method thereof, in particular a kind of method by spray drying method for preparation magnetic near-infrared fluorescent microballoon and gold microsphere, and the fluorescent microsphere that obtains is used for belonging to nanotechnology, chemical and biomedical crossing domain in mark spike, medical diagnosis on disease and the treatment of biomedicine.
Background technology
The fluorescent mark tracer technique is a column technology of field of biology, and the material of energy emitting fluorescence also comprises the semiconductor-quantum-point nanoparticle except traditional organic fluorescent dye molecule and gold nano grain, in addition, also has rare-earth compound.They not only can be used as a kind of probe of fluorescent mark spike, can also be used for especially tumor treatment of disease.
Since the research group of the research group of Nie in 1998 and Alivisators was delivering the significant paper that quantum dot is used as the nano biological fluorescent probe in succession on " Science " since, quantum dot had caused in the world that in bio-medical applications investigators pay close attention to widely.Quantum dot is in bio-medical applications, can make people more in depth understand in the signal transduction, gene chip of mechanism of action, the cell of medicine the interaction between the protein and oncomolecularbiology mechanism etc., and can reduce the workload that people encode to Human genome.The quantum size effect of quantum dot makes the scientific research in fields such as its Clinics and Practices to disease, pharmacy, cytobiology, genomics, proteomics and molecular biology produce huge and far-reaching influence.
Near infrared fluorescence quantum point is meant the semiconductor nano crystallite at the near-infrared region emitting fluorescence, comprise the near infrared fluorescence quantum point nanoparticle of forming by single semiconductor material, with a kind of semi-conductor nano particles is nuclear, another kind of inorganic materials is the core-shell type near infrared fluorescence quantum point nano-complex particle of shell, and the nano-complex particle of near infrared fluorescence quantum point quantum well structure etc.The optical property of near infrared fluorescence quantum point is stable, the fluorescence quantum yield height.Under the exciting of near infrared light, the heat effect that near-infrared fluorescent produced of near infrared fluorescence quantum point emission is enough to the kill tumor cell.
The material that can produce near-infrared fluorescent also has the near-infrared fluorescent organic dye molecule, and it is a mark tracer material biologically commonly used, comprises rhodamine class dyestuff, the flower cyanine type dye, the sour cyanine type dye in side, thiazides and mouthful oxazines class dyestuff, phthalocyanines and complex compound dyestuff thereof, BODIPY class dyestuff etc.These near infrared organic dye have at the aspects such as early diagnosis of DNA sequencing by hybridization, immunodetection, gene recombination detection, tumour widely to be used, and the near-infrared fluorescent of these dye molecule emissions also can be used in the thermotherapy of tumour.
Gold nano grain is a fluorescent probe biologically commonly used, and golden nanometer particle itself can generate heat after absorbing near infrared light, can be used for the thermotherapy of tumour.
Tumor thermotherapy is a kind of physiatrics, and at home and abroad extremely people pay close attention to.The principle of thermotherapy method is the heat-resisting difference of utilizing between normal cell and the cancer cells, the cancer cells position is heated to about 43 ℃ and makes cancer cell death.The method of tumor thermotherapy comprises radio-frequency (RF) ablation thermotherapy between tissue, energy focusing ultrasonic-high, microwave heat therapeutic and by the whole body heating fervescence to 39.5 ℃～41.5 ℃ kept carried out thermotherapy in 2～4 hours, etc.In addition, studies show that the heat that can utilize magnetic nanoparticle to produce is come killing tumor cells under action of alternating magnetic field.
Recently, the researchists such as L.R.Hirsch of U.S. Rice University and University of Texas are adsorbed onto gold nano grain on the nano silicon particles, and the silicon that forms with 110 ± 10nm is nuclear, and the gold of 10nm thickness is the core-shell type nano composite particle of shell.They are with this nano particle injection experiments mouse tumor locus, and adopt near infrared light to excite, nano particle very fast generation heat after absorbing near infrared light as a result, within 4 to 6 minutes, tumour is just too high and deadly because of internal temperature, and the not impaired [L.R.Hirsch of health tissues around the tumour, etal.Nanoshell-mediated near-infrared thermal therapy oftumors under magnetic resonace guidance.PNAS, 2003,100 (23): 13549-13554].These studies show that nanotechnology can be used for the thermotherapy of tumour, but also thermotherapy method that may be more traditional has better superiority.
People's such as L.R.Hirsch method can make tumour cell and be organized in the very short time and be subjected to being subjected to kill and wound with regard to Yin Re, and normal cell and tissue can escape injury, this is nanotechnology and biomedical extraordinary the combination, is significant for tumor treatment.Yet the nano-complex particle of people such as L.R.Hirsch preparation does not possess the function of targeted therapy tumour.And exposed metal nanoparticle is the possibility release metal ions in vivo, to the organism toxigenicity.
Summary of the invention
At the deficiency that prior art exists, one of purpose of the present invention is to provide a kind of fluorescent microsphere;
Two of purpose of the present invention is to provide the preparation method of this fluorescent microsphere;
Three of purpose of the present invention is to provide the application of this fluorescent microsphere.
Goal of the invention of the present invention is achieved by the following technical solution:
A kind of fluorescent microsphere, form by polymer, near-infrared fluorescent material and magnetic particle or by polymer, gold nano grain and magnetic particle, a kind of in the organic molecule that described near-infrared fluorescent material is near infrared fluorescence quantum point or near-infrared fluorescent, when being near infrared fluorescence quantum point or gold nano grain, the composition of fluorescent microsphere and proportioning are: magnetic particle 0.1～40wt%, near infrared fluorescence quantum point or gold nano grain 1～50wt%, surplus is a polymer; When being the organic molecule of near-infrared fluorescent, the composition of fluorescent microsphere and proportioning are: magnetic particle 0.1～90wt%, and the organic molecule 0.01～5wt% of near-infrared fluorescent, surplus is a polymer.Above percentage ratio is weight percentage.
Can also in the mixing solutions of polymer, near-infrared fluorescent material and magnetic particle, add cancer therapy drug, perhaps in the mixing solutions of polymer, gold nano grain and magnetic particle, add cancer therapy drug.
Described microballoon is to preserve with the dried powder state, or directly is dispersed in aqueous phase that aqueous phase contains tensio-active agent, the polymer that strengthens the microballoon suspension stability, and these tensio-active agents or high molecular concentration are 0.05～5wt%; Described microballoon be shaped as sphere, elliposoidal, landing umbrella shape or other are irregularly shaped, particle diameter is 0.5～20 μ m.
Described microballoon, finishing have one or more the biomolecules in antibody, part, polypeptide, cytokine, nucleic acid or the semi-lactosi, act as absorption, chemical bonding between they and the microballoon.
Near-infrared fluorescent material of the present invention is meant near infrared fluorescence quantum point, refer in particular to elementary composition semiconductor nano crystallite at the near-infrared region emitting fluorescence by II-VI family or III-V family, comprise the near infrared fluorescence quantum point nanoparticle that single semiconductor material is formed, as InP, InAs, CdTe, HgS, HgSe, etc.; With a kind of semi-conductor nano particles is nuclear, and another kind of inorganic materials is the core-shell type near infrared fluorescence quantum point nano-complex particle of shell, as CdS/HgS, and HgS/CdS, CdTe/HgTe, CdSe/HgSe, InAs/ZnSe etc.; And the nano-complex particle of near infrared fluorescence quantum point quantum well structure such as CdSe/HgSe/CdSe, any one among the CdS/HgS/CdS etc. or several combination arbitrarily.The near infrared fluorescence quantum point granularity is 2～20nm.The near infrared fluorescence quantum point nanoparticle surface can be modified and can be strengthened particle stability or strengthen the particle wetting ability or the oil loving molecule of enhancing particle, as hydrophilic molecule, hydrophobic molecule, tensio-active agent etc.
Described near-infrared fluorescent material is meant that all can launch the organic molecule of near-infrared fluorescent under the exciting of light, comprise rhodamine class dyestuff, the flower cyanine type dye, the sour cyanine type dye in side, thiazides and mouthful oxazines class dyestuff, phthalocyanines and complex compound dyestuff thereof, BODIPY class dyestuff etc. can be launched any one or several combination arbitrarily in any class in the organic molecule of near-infrared fluorescent.
Described magnetic particle is meant martial ethiops, refers in particular to a kind of in Z 250 and the ferric oxide, and granularity is between 1nm～50nm.The magnetic particle modified surface can strengthen particle stability or strengthen the particle wetting ability or strengthen the oil loving molecule of particle, as hydrophilic molecule, hydrophobic molecule, tensio-active agent etc.
Described polymer is meant natural polymer, the combination of any one or a few in semi-synthetic polymer and the synthetic macromolecule.Described polymer refers in particular to human serum albumin, bovine serum albumin, calf casein, egg albumen, zein, starch, gelatin, gum arabic, alginates, chitosan, methylcellulose gum, ethyl cellulose, carboxymethyl cellulose, carboxylic third methylcellulose, cellulose acetate-phthalate, the d ritalinic acid Mierocrystalline cellulose, the succsinic acid cellulose acetate, polyamino acid, poly-carbon ester, polymethylmethacrylate, polyethyl methacrylate, polyacrylic resin, poly(lactic acid), the polylactic acid-polyglycol segmented copolymer, polymeric anhydride, Vicryl Rapide, 6-caprolactone rac-Lactide segmented copolymer, Sensor Chip CM 5, any one in the polystyrene or several combination arbitrarily.
Preparation method of the present invention is as follows:
The present invention obtains microballoon with the mixing solutions of polymer, near-infrared fluorescent material and magnetic particle by spray drying process, and forming with near-infrared fluorescent material and magnetic particle is core, and polymer is the composite particles of skeleton.
The present invention also obtains microballoon with the mixing solutions of polymer, gold nano grain and magnetic particle by spray drying process, and forming with gold nano grain and magnetic particle is core, and polymer is the composite particles of skeleton.
Describedly obtain microballoon by spray drying process, mixing solutions is to be atomized into drop by in pneumatic atomizer, pressure atomizer, rotary atomizer, the ultrasonic atomizer any one.The exsiccant mixing solutions concentration of waiting to spray is 0.1～60wt%, and input speed is 0.5～100mLmin
-1, inlet temperature is 10～200 ℃, air outlet temperature is regulated automatically by equipment.Carrier gas is rare gas element or air.Speed and the kind of spray-dired solution, the viscosity of solution that the present invention will fly by atomizing situation, drying temperature, the drop that changes spray-drying process wait pattern and the size-grade distribution of controlling microballoon.Spraying drying is a solvent with water or with the organic solvent, obtains sphere, elliposoidal, landing umbrella shape and other are irregularly shaped, and particle diameter is 0.5～20 μ m.
Describedly obtain microballoon, be meant that spray-dired mixing solutions is heated and makes solvent evaporates in the kiln internal cause, directly obtains water-fast microballoon by spray drying process.Or, further make the polymer (as protein) in the microballoon that sex change take place by heating by behind the spraying drying acquisition microballoon, obtain water-fast microballoon.Perhaps be meant in the exsiccant mixing solutions of waiting to spray to add glue crosslinking agent, then spraying drying.In the microballoon that obtains, embedded magnetic particle and near-infrared fluorescent material or embedded magnetic particle and gold nano grain simultaneously simultaneously.
During the preparation spray drying soln, can in the mixing solutions of polymer, near-infrared fluorescent material and magnetic particle, add cancer therapy drug, perhaps in the mixing solutions of polymer, gold nano grain and magnetic particle, add cancer therapy drug, carry out spraying drying by above-mentioned arbitrary method then.The microballoon that obtains can further be removed solvent residual in the microballoon by heat drying or lyophilize.
When described microballoon is used in biology or the human body, microballoon is sterilized, sterilization method is a kind of in heat sterilization or pressure sterilizing or Entkeimung or uv light irradiation or other aseptic techniques.
Described microballoon is used for tumor treatment.Utilize magnetic nanoparticle under the guiding in magnetic field, microballoon to be targeted to tumor locus or be fixed on tumor locus, place excitation light source at tumor locus, treat tumour under the exciting of exciting light by the heat effect that near-infrared fluorescent material or gold nano grain are produced; Or utilize the toxic action of cancer therapy drug and the heat effect of near-infrared fluorescent material or gold nano grain generation to treat tumour simultaneously.Described microballoon also is used for biomedical mark tracer study, as the imaging of immunodetection, DNA hybridization and order-checking, cell and histoorgan.
The present invention is embedded in near-infrared fluorescent material and magnetic particle in the polymer microsphere by spray drying process, and forming with near-infrared fluorescent material and magnetic particle is core, and polymer is the composite particles of skeleton.The present invention also obtains microballoon with the mixing solutions of polymer, gold nano grain and magnetic particle by spray drying process, and forming with gold nano grain and magnetic particle is core, and polymer is the composite particles of skeleton.All right further embedding cancer therapy drug in the composite particles, the surface can also connect the biomolecules with recognition function.Fluorescent microsphere provided by the invention has advantages such as magnetic target therapy, good biocompatibility, optical property be stable, can be used in the thermotherapy of mark spike in the biomedicine and tumour.In addition, the spray drying process that adopts of the present invention has the microballoon granularity and advantage such as pattern is easy to control, efficient is high, can produce in batches.In the diagnosis of biomedical mark spike, tumour and thermotherapy, have broad application prospects.
Embodiment
How further specify the present invention below in conjunction with specific embodiment realizes:
Embodiment 1:
Near infrared fluorescence quantum point CdTe, nanometer Fe with an amount of concentration
3O
4And bovine serum albumin (BSA) aqueous solution mixes, as spray-dired precursor solution.In this precursor solution, solute concentration is 30wt%.During spraying drying, input speed is 5mLmin
-1, inlet temperature is 60 ℃, 50 ± 2 ℃ of air outlet temperatures, atomizing disk rotating speed are 20000rmin
-1Carrier gas is an air.The powder that obtains continues dry down at 120 ℃, make the BSA sex change.
The result obtains the exsiccant powdered sample, and microscopic appearance is spherical, and granularity is 1～3 μ m, when BSA concentration is 1wt% in forerunner's liquid solution, acquisition be the more slick microballoon in surface of rule; When BSA concentration was 20wt% in forerunner's liquid solution, the part microsphere surface had depression and hole.All microballoons are all water insoluble, under fluorescent microscope red fluorescence arranged, and in test tube, available magnet attracts a side in test tube wall with powder.In addition, by adjusting CdTe and Fe
3O
4And the add-on of BSA, can obtain to contain the BSA microballoon of 0.1～40wt% magnetic particle, 1～50wt%CdTe easily.
Embodiment 2:
Near infrared fluorescence quantum point CdTe, nanometer Fe with an amount of concentration
3O
4And bovine serum albumin (BSA) aqueous solution mixes, as spray-dired precursor solution.In this precursor solution, solute concentration is 60wt%, and during spraying drying, input speed is 0.5mLmin
-1, inlet temperature is 60 ℃, 50 ± 2 ℃ of air outlet temperatures, atomizing disk rotary speed are 20000rmin
-1Carrier gas is an air.The powder that obtains continues dry down at 120 ℃, make the BSA sex change.
The result obtains the spheroidal particle that granularity is 5～20 μ m, its optical property, magnetic property and water-soluble etc. similar to the product of embodiment 1.
Embodiment 3:
Near infrared fluorescence quantum point CdTe, nanometer Fe with an amount of concentration
3O
4And bovine serum albumin (BSA) aqueous solution mixes, as spray-dired precursor solution.In this precursor solution, solute concentration is 0.1wt%, and during spraying drying, input speed is 100mLmin
-1, inlet temperature is 200 ℃, the atomizing disk rotary speed is 20000rmin
-1Carrier gas is an air.
The result obtains the particle that granularity mainly is distributed in 800nm～3 μ m, and individual particles only is 500nm.Most of microsphere surface has depression and hole, and microballoon is water insoluble.Its optical property, magnetic property and water-soluble etc. also similar to the product of embodiment 1.
Embodiment 4:
With gold nano grain solution and Fe
3O
4The nano particle aqueous solution and the BSA aqueous solution mix, and in the mixed solution, solute concentration is 4wt%, and wherein BSA accounts for 3wt%.Input speed is 5mLmin
-1, inlet temperature is 100 ℃, and air outlet temperature is 85 ℃, and the atomizing disk rotating speed is 20000rmin
-1Collect powder.
The result shows that the product overwhelming majority of acquisition is spherical, and granularity mainly is distributed in 3～10 μ m, and is rough.In test tube, available magnet attracts a side in test tube wall with powder.Under fluorescent microscope, red fluorescence is arranged.
Embodiment 5:
With the near infrared fluorescence quantum point CdTe solution of an amount of concentration of 20mL, the nanometer Fe of an amount of concentration of 20mL
3O
4Solution and 50mL concentration are mixed for the 0.1wt% chitosan, and adding glutaraldehyde or the formaldehyde that 1mL concentration is 0.1wt% then is linking agent, after the mixing, carries out spraying drying, and input speed is 5mLmin
-1, inlet temperature is 120 ℃, and air outlet temperature is 90 ~ 95 ℃, and the atomizing disk rotating speed is 20000rmin
-1
The result shows, acquisition be the spherical powder particle of 5～20 μ m, in test tube, also available magnet attracts a side in test tube wall with powder.Under fluorescent microscope, bright red fluorescence is arranged.
Embodiment 6:
With an amount of near infrared fluorescence quantum point CdTe powder and an amount of nanometer Fe
3O
4Powder joins in the ethanolic soln that 50mL concentration is the 1wt% ethyl cellulose and mixes, and ultrasonication 10 minutes is as spray-dired precursor solution.Input speed is 5mLmin during spraying drying
-1, inlet temperature is 10 ℃, the atomizing disk rotating speed is 20000rmin
-1To the product that obtains further at 80 ℃ of dry 1h.
The result shows, acquisition be exsiccant powder very, the product overwhelming majority is a sphere, small part is a hollow granule, granularity is 2～10 μ m.The magnetic of microballoon is similar to embodiment 1 with fluorescence.
Embodiment 7:
With the maximum emission wavelength is that 680nm silicon phthalocyanine derivative (LaJolla Blue) replaces the CdTe among the embodiment 1, presses embodiment 3 identical methods and prepares embedding LaJollaBlue and Fe simultaneously
3O
4Microballoon.
The pattern of the microballoon that the result obtains and size-grade distribution and embodiment 1 are approaching.Stronger fluorescence and magnetic are arranged.
Embodiment 8:
With an amount of Zorubicin, near infrared fluorescence quantum point CdTe powder and nanometer Fe
3O
4Powder joins in the ethanolic soln that 50mL concentration is the 1wt% ethyl cellulose and mixes, and ultrasonication 10 minutes is carried out spraying drying then, and input speed is 5mLmin
-1, inlet temperature is 50 ℃, the atomizing disk rotating speed is 20000rmin
-1The product that obtains is lyophilize 10h again, to remove residual ethanol.
The result obtains the incarnadine powder, and the granularity of product is similar to embodiment 1 to pattern, and available magnet is inhaled a side in test tube wall with powder.Under fluorescent microscope, powder particle has bright red fluorescence.
Embodiment 9:
Embedding CdTe and Fe in the time of with embodiment 1 preparation
3O
4BSA powder microballoon be raw material, they are scattered in respectively in the physiological saline that contains 0.2%Tween-80, be designated as microballoon 1; Embedding Zorubicin, CdTe and Fe in the time of in addition with embodiment 8 preparations
3O
4The ethyl cellulose microballoon be raw material, they are scattered in respectively in the physiological saline that contains 0.2%Tween-80, be designated as microballoon 2.
Get 20 of Balb/C mouse, body weight is 20 ± 2g, and is female.S180 cell on the left back shank kind of mouse, the tumour size is about 0.5～1cm behind the fortnight.Divide 5 groups at random with mouse, 4 every group.
To the 1st group of mouse: shave off the chaeta at mouse tumor position, get microballoon 1 suspension 0.3mL, carry out injecting in the knurl, above tumour, place a disc magnet, and adopt near infrared light to excite tumor locus.
To the 2nd group of mouse: shave off the chaeta at mouse tumor position, get microballoon 1 suspension 0.3mL, carry out injecting in the knurl, above tumour, place a disc magnet.
To the 3rd group of mouse: shave off the chaeta at mouse tumor position, get microballoon 2 suspension 0.3mL, carry out injecting in the knurl, above tumour, place the disc magnet that diameter is 1cm, and adopt near infrared light to excite tumor locus.
To the 4th group of mouse: shave off the chaeta at mouse tumor position, get microballoon 2 suspension 0.3mL, carry out injecting in the knurl, above tumour, place the disc magnet that diameter is 1cm.
To the 5th group of mouse: shave off the chaeta at mouse tumor position, then without any other processing.
Experiment through 7～10 found that, the 5th group of mouse of comparing, and the tumor growth of the 1st, 3,4 group of mouse obviously is suppressed, and wherein the tumour of the 3rd group of mouse is dwindled the most significantly.The growth of tumor of the 2nd group of mouse also has certain inhibition.
Embodiment 10:
Embedding CdTe and Fe in the time of with embodiment 1 preparation
3O
4BSA powder microballoon be scattered in the deionized water, mix to wherein adding an amount of semi-lactosi then, coupling is 3 hours under the room temperature.
The result has obtained the magnetic albumin fluorescent microsphere that finishing has semi-lactosi, this microballoon has initiatively and the function of passive dual-target (or location) treatment, can be used for receptor-mediated targeted therapy, also can be used as identification that fluorescent probe is used for cell and separate.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510025591 CN1693416B (en) | 2005-04-29 | 2005-04-29 | A kind of fluorescent microsphere and its spray-drying preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510025591 CN1693416B (en) | 2005-04-29 | 2005-04-29 | A kind of fluorescent microsphere and its spray-drying preparation method and application |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1693411A CN1693411A (en) | 2005-11-09 |
| CN1693416B true CN1693416B (en) | 2010-09-22 |
Family
ID=35352540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510025591 Expired - Fee Related CN1693416B (en) | 2005-04-29 | 2005-04-29 | A kind of fluorescent microsphere and its spray-drying preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1693416B (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101383212B (en) * | 2008-06-30 | 2011-05-25 | 上海师范大学 | A kind of preparation method of superparamagnetic/fluorescence nanoparticle |
| CN101787163B (en) * | 2010-03-22 | 2011-06-08 | 天津大学 | Magnetic fluorescent microspheres and preparation method thereof |
| CN101870869B (en) * | 2010-06-29 | 2013-03-13 | 同济大学 | Preparation method of porous magnetic fluorescent nanosphere |
| CN102847493A (en) * | 2012-09-17 | 2013-01-02 | 北京科技大学 | Method for water-phase dispersion of metal magnetic nano particles |
| CN105175750B (en) * | 2015-09-10 | 2017-08-08 | 河南工业大学 | A kind of preparation method of hydrogel microsphere |
| CN110951833B (en) * | 2018-09-26 | 2022-03-29 | 中国农业大学 | Detection kit and detection method for simultaneously detecting drift or deposition of multiple spraying droplets |
| CN110951832B (en) * | 2018-09-26 | 2022-05-10 | 中国农业大学 | A kit and detection method for detecting the drift or deposition characteristics of spray droplets using magnetic nano-microspheres |
| CN111722419B (en) | 2020-07-07 | 2021-11-02 | Tcl华星光电技术有限公司 | Nano composite particle and magnetic control display device |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426513B1 (en) * | 1998-09-18 | 2002-07-30 | Massachusetts Institute Of Technology | Water-soluble thiol-capped nanocrystals |
| CN1403379A (en) * | 2002-10-10 | 2003-03-19 | 武汉大学 | Prepn of CdSe/CdS or CdSe/ZnS core-shell quantum dot |
| CN1560633A (en) * | 2004-02-19 | 2005-01-05 | 上海交通大学 | Preparation method of quantum dot microspheres used as biomedical fluorescent probes |
| CN1559656A (en) * | 2004-02-19 | 2005-01-05 | 上海交通大学 | Preparation method of core-shell nanocomposite particles of magnetic particles and quantum dots |
-
2005
- 2005-04-29 CN CN 200510025591 patent/CN1693416B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6426513B1 (en) * | 1998-09-18 | 2002-07-30 | Massachusetts Institute Of Technology | Water-soluble thiol-capped nanocrystals |
| CN1403379A (en) * | 2002-10-10 | 2003-03-19 | 武汉大学 | Prepn of CdSe/CdS or CdSe/ZnS core-shell quantum dot |
| CN1560633A (en) * | 2004-02-19 | 2005-01-05 | 上海交通大学 | Preparation method of quantum dot microspheres used as biomedical fluorescent probes |
| CN1559656A (en) * | 2004-02-19 | 2005-01-05 | 上海交通大学 | Preparation method of core-shell nanocomposite particles of magnetic particles and quantum dots |
Non-Patent Citations (2)
| Title |
|---|
| CN 1559656 A,权利要求书，实施例. |
| CN 1560633 A,权利要求书，实施例. |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1693411A (en) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jin et al. | Nanoparticles modified by polydopamine: Working as “drug” carriers | |
| Chen et al. | Multifunctional mesoporous nanoellipsoids for biological bimodal imaging and magnetically targeted delivery of anticancer drugs | |
| KR102154207B1 (en) | Silver nanoplate compositions and methods | |
| Hou et al. | Electrospun upconversion composite fibers as dual drugs delivery system with individual release properties | |
| Sironmani et al. | Silver nanoparticles–universal multifunctional nanoparticles for bio sensing, imaging for diagnostics and targeted drug delivery for therapeutic applications | |
| CN108114287B (en) | Protein-polyphenol composite microspheres and preparation method and use thereof | |
| CN109453138A (en) | A kind of load medicine albumin microparticle or nanoparticle and preparation method thereof | |
| JP2007514518A (en) | Capsule of multilayer neutral polymer film bonded by hydrogen bonding | |
| Kumari | A Review on Nanoparticles: Their Preparation method and applications | |
| CN1693416B (en) | A kind of fluorescent microsphere and its spray-drying preparation method and application | |
| Liu et al. | Ag@ S-nitrosothiol core–shell nanoparticles for chemo and photothermal synergistic tumor targeted therapy | |
| CN111803629A (en) | Organic-inorganic hybrid multifunctional biological material based on nano cellulose crystals and preparation method and application thereof | |
| WO2021083370A1 (en) | Preparation and use of nanomaterial specifically activating immune system | |
| CN104288093B (en) | Application of the nano drug transdermal preparation in tumour | |
| CN105343870B (en) | A kind of keratin nanoparticle and preparation method thereof | |
| Simioni et al. | Effect of diode-laser and AC magnetic field of bovine serum albumin nanospheres loaded with phthalocyanine and magnetic particles | |
| Vaccari et al. | Biocompatible magnetic microspheres for Use in PDT and hyperthermia | |
| CN109260473A (en) | A kind of porphyrin nano compound and its preparation method and application with tumor-targeting function | |
| Singh et al. | Magnetic hybrid nanoparticles for drug delivery | |
| TWI543778B (en) | Protein-graphene nanocomposite drug carrier | |
| Sun et al. | Multi-stimuli-responsive janus hollow polydopamine nanotubes | |
| CN105561333A (en) | Nano-drug carrier and drug with synergistic action of magnetic hyperthermia-chemotherapy and preparation method of nano-drug carrier and drug | |
| CN108014092A (en) | A kind of preparation method and application of magnetic oxygenated graphene-nucleoprotamine/sodium carboxymethylcellulose compound | |
| CN1698582A (en) | Near-infrared fluorescent magnetic nanoparticles coated with silicon and its preparation method and application | |
| CN100586482C (en) | Lymphatic dye with silicon dioxide particles as carrier and its preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20100922 Termination date: 20130429 |